CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail - PubMed (original) (raw)
Comparative Study
CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail
I Stamenkovic et al. J Exp Med. 1988.
Abstract
The isolation and expression of a full-length cDNA clone encoding the B cell-specific glycoprotein CD19 is reported. The sequence of the cDNA predicts a glycosylated integral membrane protein with a precursor molecular weight of 51.8 x 10(3) and an extracellular domain organized into three contiguous Ig-like sub-domains. The cytoplasmic domain bears significant relatedness to two proteins encoded by the Epstein-Barr virus and the int-1 oncogene. CD19 transcripts are restricted to members of the B cell lineage, being most abundant in pre-B cell lines and least abundant in plasmacytomas.
Similar articles
- Molecular cloning and expression pattern of a human gene homologous to the murine mb-1 gene.
Ha HJ, Kubagawa H, Burrows PD. Ha HJ, et al. J Immunol. 1992 Mar 1;148(5):1526-31. J Immunol. 1992. PMID: 1538135 - Cloning and sequencing of the cDNA encoding the human homologue of the murine immunoglobulin-associated protein B29.
Müller B, Cooper L, Terhorst C. Müller B, et al. Eur J Immunol. 1992 Jun;22(6):1621-5. doi: 10.1002/eji.1830220641. Eur J Immunol. 1992. PMID: 1534761 - The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity.
Fearon DT, Carter RH. Fearon DT, et al. Annu Rev Immunol. 1995;13:127-49. doi: 10.1146/annurev.iy.13.040195.001015. Annu Rev Immunol. 1995. PMID: 7542009 Review.
Cited by
- A narrative review of critical factors for better efficacy of CD19 chimeric antigen receptor T cell therapy in the treatment of B cell malignancies.
Liu J, Wang L, Yang H, Xing M, Liu S, Yu Z, Ma L. Liu J, et al. Transl Cancer Res. 2020 Sep;9(9):5655-5662. doi: 10.21037/tcr-20-1044. Transl Cancer Res. 2020. PMID: 35117929 Free PMC article. Review. - Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients.
Maschan M, Caimi PF, Reese-Koc J, Sanchez GP, Sharma AA, Molostova O, Shelikhova L, Pershin D, Stepanov A, Muzalevskii Y, Suzart VG, Otegbeye F, Wald D, Xiong Y, Wu D, Knight A, Oparaocha I, Ferencz B, Roy A, Worden A, Kruger W, Kadan M, Schneider D, Orentas R, Sekaly RP, de Lima M, Dropulić B. Maschan M, et al. Nat Commun. 2021 Dec 10;12(1):7200. doi: 10.1038/s41467-021-27312-6. Nat Commun. 2021. PMID: 34893603 Free PMC article. - Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies.
Kikushige Y. Kikushige Y. J Clin Exp Hematop. 2020 Dec 15;60(4):146-158. doi: 10.3960/jslrt.20036. Epub 2020 Nov 4. J Clin Exp Hematop. 2020. PMID: 33148933 Free PMC article. Review. - _N_-Glycan Branching Is Required for Development of Mature B Cells.
Mortales CL, Lee SU, Demetriou M. Mortales CL, et al. J Immunol. 2020 Aug 1;205(3):630-636. doi: 10.4049/jimmunol.2000101. Epub 2020 Jun 26. J Immunol. 2020. PMID: 32591389 Free PMC article. - Adoptive Cell Therapy-Harnessing Antigen-Specific T Cells to Target Solid Tumours.
Chruściel E, Urban-Wójciuk Z, Arcimowicz Ł, Kurkowiak M, Kowalski J, Gliwiński M, Marjański T, Rzyman W, Biernat W, Dziadziuszko R, Montesano C, Bernardini R, Marek-Trzonkowska N. Chruściel E, et al. Cancers (Basel). 2020 Mar 13;12(3):683. doi: 10.3390/cancers12030683. Cancers (Basel). 2020. PMID: 32183246 Free PMC article. Review.
References
- Nucleic Acids Res. 1984 Jan 25;12(2):857-72 - PubMed
- Nature. 1984 Jul 19-25;310(5974):207-11 - PubMed
- J Virol. 1985 Jun;54(3):665-74 - PubMed
- EMBO J. 1985 Nov;4(11):2905-9 - PubMed
- Nucleic Acids Res. 1986 Jun 11;14(11):4683-90 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases